ISPH: Summary for Inspire Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 5:54am EST - Canadian Markets open in 3 hours and 36 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Inspire Pharmaceuticals, Inc. (ISPH)

On Feb 9: 5.49 USD 0.00 (0.00%)

MORE ON ISPH

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Inspire Pharmaceuticals, Inc. (NGM:ISPH) Delayed quote data

Last Trade:	5.49 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	5.49
Open:	N/A
Bid:	5.11 x 100
Ask:	N/A
1y Target Est:	9.60

Day's Range:	N/A - N/A
52wk Range:	2.59 - 7.03
Volume:	0
Avg Vol (3m):	639,638
Market Cap:	451.83M
P/E (ttm):	N/A
EPS (ttm):	-0.78
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add ISPH to Portfolio

Download Data

HEADLINES

•	Inspire Announces Webcast of Presentation at BIO CEO Conference
	Business Wire (Thu, Feb 4)

•	Biotech's Latest Failed Trials, Missed Targets
	at Seeking Alpha (Mon, Jan 25)

•	INSPIRE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
	EDGAR Online (Thu, Jan 21)

•	Inspire shares fall on failed eye drug study
	AP (Thu, Jan 21)

•	UPDATE - Inspire Pharma eye drug fails in late-stage trial
	at Reuters (Thu, Jan 21)

•	Early-Market Movers: SunOpta, Sinovac Biotech
	at Fox Business (Thu, Jan 21)

•	Inspire dry eye treatment fails late-stage study
	AP (Thu, Jan 21)

•	Blockbuster, CalAmp: Early Volume Plays
	at TheStreet.com (Thu, Jan 21)

•	Inspire Dry Eye Drug Fails Key Test: BioBuzz
	at TheStreet.com (Thu, Jan 21)

•	Inspire Phase 3 trial fails to meet endpoints
	at MarketWatch (Thu, Jan 21)

•	Inspire Announces Results of Phase 3 PROLACRIA Trial for Dry Eye
	Business Wire (Thu, Jan 21)

More Headlines for ISPH...

ANALYST

EPS Est (next year) (Dec-09) :	-0.69
EPS Est (in 2 years) (Dec-10) :	-0.53
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Inspire Pharmaceuticals, Inc., a biopharmaceutical company, engages in researching, developing, and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases.

Full Company Profile

Add to Portfolio

Email to a Friend

•